After success with convalescent plasma therapy against coronavirus, Odisha is set to test the COVID-19 vaccine ‘Covaxin’ at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar. The human clinical trial of the vaccine will be done as per the guidelines set by the Drugs Controller General of India (DCGI).

On Monday, a Preventive and Therapeutic Clinical Trial Unit (PTCTU) was inaugurated at the institute for the human trial. Principal investigator of the trial process at the hospital Dr E Venkat Rao called the special laboratory “dedicated human trial unit” in Odisha.

“People willing to volunteer for the vaccine trial can contact the institute. All details are displayed on its website,” Rao said as quoted by

“We will screen the prospective volunteers and thoroughly evaluate their health condition before administering them the vaccine,” he added.

Rao added that healthy volunteers should be aged between 18 and 55 years and should not have any comorbid conditions or COVID-19 history.

“We are committed to the maintenance of quality, ethics, patient safety and confidentiality at the highest level. We conduct clinical trials involving investigational drugs or molecules approved by the DCGI and the Central Drug Standardisation Control Organisation (CDSCO),” Rao said.